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This case report describes a sternoclavicular infection in an IV drug user. The history and physical 
exam suggested an abscess. In the emergency department (ED) the patient refused incision and 
drainage but did consent to simple needle aspiration. Subsequent culture of the aspirate revealed 
Pseudomonas aeruginosa. He was admitted for IV antibiotics. After admission, a bone scan 
suggested the presence of osteomyelitis. The patient refused operative débridement, but ultimately 
did consent to bedside incision and drainage. By day five, the fever had resolved and the patient 
signed out AMA. He was given a prescription for Ciprofloxacin. The patient had an unscheduled follow 
up in the ED five months later for an unrelated heroin overdose. Physical examination demonstrated 
complete resolution of the infection.
[WestJEM. 2008;9:112-114.]
INTRODUCTION
Bacterial septic arthritis is dangerous and destructive. 
Early intervention is key to prevent irreversible joint 
damage and hematogenous spread. In the United States, 
the most common etiology of septic arthritis is Neisseria 
gonorrhea.1 Sternoclavicular joint and sacral iliac joint 
infections are associated with intravenous drug use (IVDU). 
Methicillin-resistant Staphylococcus aureus (MRSA) has 
surpassed Pseudomonas aeruginosa as the most common 
cause of sternoclavicular septic arthritis.2 While one case of 
sternoclavicular septic arthritis due to Staphylococcus aureus 
has been published in the emergency medicine literature,3 we 
present the first case of septic arthritis of the sternoclavicular 
joint due to Pseudomonas aeruginosa. 
CASE REPORT
Chief Complaint
“I’m growing a breast.” 
HISTORY
A 28-year-old man presented to the emergency 
department (ED) with a painful fluctuant swelling in the left 
anterior chest. He first noticed the swelling one week prior 
when a friend joked he was growing a breast. Since that time, 
the area has become progressively more swollen. He also 
reported fevers and chills for the past two days. The pain was 
worse with arm movement. The patient has used IV heroin for 
three years, most recently just prior to the ED visit, and most 
commonly injected his arms. The patient reused his needles 
after cleaning them in vodka. He denied any IVDU in the neck 
or chest and had never had similar swellings in the past. He 
denied skin popping and pocket shooting. Past medical history 
was unremarkable. The patient had never been tested for 
hepatitis, HIV, or sexually transmitted diseases. Last tetanus 
toxoid was two years ago. He denied sharing needles. 
PHYSICAL EXAM
The patient appeared in mild discomfort. Vital signs were 
pulse of 102 beats per minute, blood pressure of 140/72 mm 
Hg, respiratory rate at 18 breaths per minute and temperature 
99.6 °F orally.
The head exam was normal; the neck revealed several 
small (<1cm) mobile lymph nodes primarily on the left 
side of the neck anterior to the sternocleidomastoid muscle. 
Chest exam revealed a 3 x 4 cm tender, fluctuant, nodular 
mass in the area of the left sternoclavicular joint (Figure). 
There was no overlying erythema or other skin lesions on 
the chest. The cardiovascular exam revealed no murmurs; 
peripheral pulses were strong and equal. The abdominal exam 
revealed normal bowel sounds; it was soft and non-tender 
with no organomegaly. The extremities had track marks, 
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left arm caused pain localized to the swelling. There was no 
physical exam evidence of embolic phenomena (no Osler’s 
nodes, Janeway lesions, splinter hemorrhages, Roth spots, or 
conjunctival petechiae.)
DIAGNOSTIC TESTING
The CBC revealed a white count of 13, 500/mm³. The 
hemoglobin was 13.5 g/dl. Platelets were 459,000/mm³. 
The sedimentation rate was 97 mm/hr. Electrolytes, liver 
panel, renal function and urinalysis was normal. A chest 
radiograph was normal with no bony destruction in the area 
of swelling. The patient refused incision and drainage of the 
suspected abscess. After a lengthy discussion and education 
on the increasing frequency of resistant organisms found in 
abscesses, he consented only to a diagnostic needle aspiration. 
Using sterile technique, the area was prepped and draped. 
Two cc’s of 1% lidocaine was infiltrated subcutaneously. 
Then, an 18G needle was easily inserted into the center of the 
abscess yielding 12 cc of purulent fluid. Diagnostic studies of 
the aspirate included a gram stain, cell count, and culture and 
sensitivity. Cell count revealed 78,000 WBCs /mm³ and gram 
stain showed gram-negative rods. Wound culture and two 
blood cultures were sent. 
DIAGNOSIS
Sternoclavicular septic arthritis and abscess. 
TREATMENT
In the ED, the patient received IV vancomycin and 
ceftazidime. After admission, the orthopedic service incised, 
drained, and irrigated the abscess at the bedside. The 
initial aspirate was positive for Pseudomonas aeruginosa, 
sensitive to ceftazidime and ciprofloxacin. Blood cultures 
were negative. An echocardiogram revealed no valvular 
abnormalities or vegetations. HIV, hepatitis B and C testing 
were negative. A bone scan revealed osteomyelitis in the area 
of the left sternoclavicular joint and clavicle. Orthopedics 
further recommended surgical irrigation and débridement of 
the joint space, but the patient refused. The fever subsided on 
hospital day three and the patient signed out AMA on day five, 
with a prescription for 30 additional days of oral ciprofloxacin. 
He did not follow up at the clinic.
Although he missed his clinic follow up, he did return for 
further care five months later for a subsequent overdose that 
required treatment with naloxone. When lucid, he reported 
taking the entire course of Cipro because he did not want to 
get “shooter’s heart.” He no longer had pain or swelling in the 
area, or any fevers, and said he felt fine (except for the acute 
withdrawal symptoms). 
DISCUSSION 
This case illustrates the difficulty in the evaluation of 
some ED patients. Many IVDUs are reluctant to cooperate 
with a complete medical evaluation for a number of reasons: 
fear of narcotic withdrawal, drug intoxication, lack of 
health insurance, social stigma, just to name a few. Signing 
out against medical advice is a common problem in this 
population. These patients often have serious medical 
problems and can present a high liability to the emergency 
physician. Patient education is critically important. 
Additionally, infections in this patient population require rapid 
evaluation and early antibiotic administration due to the high 
morbidity and mortality.
Sternoclavicular abscess is a potential complication of 
septic arthritis of the sternoclavicular joint,4,5 found in 22% 
of cases. The mean age is 45 years, with 74% male.2 Patients 
often present with a painful swelling over the sternoclavicular 
joint preceded by chest pain or pain referred to the neck or 
shoulder. Fever and leukocytosis are of little help, as 35% 
are afebrile and 44% have a normal WBC.2 An erythrocyte 
sedimentation rate (ESR) is more sensitive at 91%,6 but 
merely indicates inflammation not specific to any organism.7 
Bacteremia occurs in 62% of patients with sternoclavicular 
septic arthritis, with osteomyelitis occurring 55% of the time, 
and mediastinitis, 13%. Currently, Staphylococcus aureus 
is the most common bacteria in sternoclavicular abscess 
formation in IVDU patients. However, this represents a shift, 
as Pseudomonas aeruginosa was responsible for the bulk of 
cases (82%) prior to 1981, whereas Staphylococcus aureus 
caused most cases (77%) after 1981.8
Two factors may help explain why pseudomonas was 
the most common gram-negative pathogen, and why, more 
recently, S. Aureus has dominated. First, the IVDU drug of 
choice prior to 1981 was commonly pentazocine, which was 
frequently injected with the adjuvant, tripelennamine. This 
first-generation ethylenediamine antihistamine was thought 
to intensify the “rush” associated with pentazocine injection. 
One study found that tripelennamine favored the growth 
and survival of certain serotypes of pseudomonas.8 This, 
in combination with the routine use of contaminated water 
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sources to clean needles,9,10 made pseudomonas the most 
common organism causing sternoclavicular septic arthritis in 
IVDU patients prior to 1981.2
Second, a shift in the illicit drug of choice from 
pentazocine to heroin more recently may have contributed 
to the observed shift in bacteriology. Prior to the 1980s, the 
commonly used pentazocine did not require heating prior 
to injection. Therefore, pseudomonas remained the more 
common offending organism. Heroin has now surpassed 
pentazocine use.11 Because heroin requires heating prior 
to injection, bacterial contaminants are eliminated. As a 
result, skin pathogens predominate as the most common 
organisms. These factors, in our opinion, help to explain both 
the historical predominance of Pseudomonas aeruginosa as 
the cause of sternoclavicular septic arthritis, as well as its 
replacement as the predominant organism by staphylococcus.2 
Thus, this case illustrates a declining but still important 
diagnostic consideration. 
In a recent study Staphylococcus aureus was responsible 
for half of all sternoclavicular joint infections, while 
Pseudomonas aeruginosa was responsible for only 10%.2 The 
reason for this predilection to the sternoclavicular joint may 
be the combination of surface proteins, which bind connective 
tissue and the proximity of the subclavian vein.11 Intravenous 
drug use is the most common predisposing risk factor for 
sternoclavicular septic arthritis (21%), followed by upper 
extremity infection (15%), diabetes mellitus (13%), trauma 
(12%) and subclavian catheters (9%). However, almost one 
quarter of patients with sternoclavicular septic arthritis have 
no risk factors.2
The presentation of septic arthritis does not inform the 
etiology of the infection. However, Pseudomonas aeruginosa 
can give rise to blue-green pus. Occasionally, a breakdown 
product of hemoglobin called verdoglobin can be detected 
in pseudomonas infections by ultraviolet light in suspect 
wounds.12 Pseudomonas also has a characteristic “fruity-
musty” odor.13 The most specific lesion for a pseudomonas 
infection is ecthyma gangrenosum, which is a hemorrhagic 
necrosis of skin that does not contain pus, and is due to 
pseudomonas infection.12
Treatment includes incision and drainage of a suspected 
sternoclavicular abscess, as well as wound and blood cultures 
(at least three if endocarditis is suspected). In this case, the 
patient would not allow incision and drainage of the abscess. 
Surgical incision and drainage is considered the definitive 
treatment of a soft-tissue abscess.14 Diagnostic needle 
aspiration is recommended if one is unsure of pus localization. 
It should not be considered a substitute for incision and 
drainage.15
The evaluation and management of suspected soft-tissue 
infections and abscesses in febrile IVDUs must be done 
rapidly. Diagnostic evaluation includes lab tests, blood and 
wound cultures, and incision and drainage of the abscess. 
The timely administration of empiric antibiotics should 
include coverage for MRSA and pseudomonas species (e.g. 
vancomycin and ceftazidime). Gram stain and culture of the 
sternoclavicular abscess will help guide antibiotic selection, 
especially with the increasing frequency of resistant organisms 
such as methicillin resistant Staphylococcus aureus (MRSA). 
Surgical debridement or resection should be considered if 
imaging studies detect osteomyelitis or spread into adjacent 
structures.1
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